BUY $ASRT
LAKE FOREST, Ill., May 19, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that Brendan O’Grady, Chief Executive Officer, will present at the virtual Alliance Global Partners Healthcare Company Showcase, taking place Wednesday, May 21, 2025.
Mr. O’Grady’s fireside chat will be webcast live at 11:20 a.m. ET. To join the event, please register here, or visit the Events & Presentations page at the Company’s investor relations website, https://investor.assertiotx.com/.
About Assertio
Assertio is a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients’ needs. Our focus is on supporting patients by marketing products in oncology, neurology, and pain management. To learn more about Assertio, visit www.assertiotx.com.
Investor Contact
Matt Kreps, Managing Director
Darrow Associates
M: 214-597-8200
This email address is being protected from spambots. You need JavaScript enabled to view it.
BUY $ASRT
| Last Trade: | US$0.71 |
| Daily Change: | 0.02 3.53 |
| Daily Volume: | 125,505 |
| Market Cap: | US$67.790M |
March 20, 2025 March 05, 2025 | |
BUY $ASRT
Assertio is a leading commercial pharmaceutical company bringing differentiated products to patients. The Company has a robust portfolio of branded prescription products in three areas: neurology, hospital, and pain and inflammation. Assertio has grown through...
CLICK TO LEARN MOREAssertio is a leading commercial pharmaceutical company bringing differentiated products to patients. The Company has a robust portfolio of branded prescription products in three areas: neurology, hospital, and pain and inflammation. Assertio has grown through...
CLICK TO LEARN MORE